Price
$270.47-0.98%Social Signal Score
Analyst Ratings
40 analysts52-week range
- Last close
- $270.47
- Off 52w high
- -5.3%
- 200-day average
- $250.83
- vs 200-day
- +7.8%
Revenue
$25.40B+40.28%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Joaquin Duato
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 141,700
- Beta
- 0.23
- Country
- US
- Piotroski score
- 6 / 9 (Middling)
- Altman Z-score
- 5.39
Financials
Revenue
$25.40B+40.3%Net Income
$210.00M-94.5%EBITDA
$2.37B-57.4%Free Cash Flow
$6.36B+14.4%EPS (diluted)
$0.09-93.8%Shares Outstanding (diluted)
2.45B-11.4%Operating Expenses
$10.94BCash & Debt
$17.23BReturn of Capital
$4.94BRevenue by Segment (annual)
$94.19BDividend per Share
$1.34Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $94.19B | $26.80B | $11.03 |
| 2024 | $88.82B | $14.07B | $5.84 |
| 2023 | $85.16B | $35.15B | $13.88 |
| 2022 | $79.99B | $17.94B | $6.83 |
| 2021 | $78.74B | $20.88B | $7.93 |
| 2020 | $82.58B | $14.71B | $5.59 |
| 2019 | $82.06B | $15.12B | $5.74 |
| 2018 | $81.58B | $15.30B | $5.75 |
| 2017 | $76.45B | $1.30B | $0.48 |
| 2016 | $71.89B | $16.54B | $6.08 |
| 2015 | $70.07B | $15.41B | $5.57 |
| 2014 | $74.33B | $16.32B | $5.86 |
| 2013 | $71.31B | $13.83B | $4.90 |
| 2012 | $67.22B | $10.85B | $3.91 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from JNJ's reported EPS growth of 8.3% a year over 13 years.
- EPS in 5 years
- $16.44
- Implied price
- $312.42
- Return from $270.47
- 2.9% a year
To earn 15.0% a year on these assumptions you'd need to buy at $155.33 — -42.6% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 13 | 16 | 19 | 22 | 25 |
|---|---|---|---|---|---|
| -1.7% | -13.4% | -9.7% | -6.6% | -3.8% | -1.3% |
| 3.3% | -9.0% | -5.1% | -1.8% | 1.1% | 3.7% |
| 8.3% | -4.6% | -0.6% | 2.9% | 6.0% | 8.7% |
| 13.3% | -0.2% | 4.0% | 7.7% | 10.9% | 13.8% |
| 18.3% | 4.2% | 8.6% | 12.4% | 15.8% | 18.8% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
64+48.72%Social Signal Score
Mentions (100)
- News (RSS)fool·7h ago·Positive
Johnson & Johnson Is on Track for $101 Billion in 2026 Sales. Is This Dividend King Still a Buy? J&J is a healthcare giant performing very well right now, but it won't be a great fit for every investor.
View source ↗ - News (RSS)fool·8h ago·Neutral
Johnson & Johnson vs. Pfizer: Which Healthcare Stock Is a Better Buy for 2027? Johnson & Johnson's drug-and-device product mix faces off against Pfizer's high-stakes oncology and obesity bets, with a valuation gap that may sway your choice.
View source ↗ - News247wallst.com·11h ago·Neutral
The Dividend Investing Strategy That Made Geraldine Weiss a Wall Street Legend Brokerage firms turned Weiss away when she tried to become an analyst. In 1966 she co-founded Investment Quality Trends and became the first woman to start an investment advisory service.
View source ↗ - News247wallst.com·1d ago·Positive
3 Reasons Dividend Aristocrats Belong in Your Roth IRA Before You Retire At the 24% bracket, a $500,000 equal-weight position in three Dividend Aristocrats returns about $10,933 a year in dividends. In a taxable account, roughly $1,640 of that goes to the IRS every year at the 15% qualified rate.
View source ↗ - News247wallst.com·1d ago·Positive
5 Dividend Kings to Buy for Lifelong Income Before the End of November Yield chasers keep learning the same lesson: A payout is only as durable as the cash flow behind it.
View source ↗ - News247wallst.com·1d ago·Negative
How Retirees Can Turn $450,000 Into Passive Income With These 5 Dividend Stocks Selling shares in a downturn can turn a temporary loss into a permanent one for retirees. Five dividend payers from five sectors might offer a way out, but each hides a risk worth knowing before you commit a dollar.
View source ↗ - Newsdefenseworld.net·1d ago·Neutral
Top Pharmaceutical Stocks To Add to Your Watchlist – November 19th Eli Lilly and Company, Insmed, Johnson and Johnson, Merck and Co., Inc., AbbVie, Pfizer, and SELLAS Life Sciences Group are the seven Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of companies that research, develop, manufacture, or sell prescription and other medicines. For investors, they offer exposure to
View source ↗ - News (RSS)zerohedge·1d ago·Negative
'No Bars Behind Bars': FCC Clears Way For Prisons To Jam Contraband Cellphones 'No Bars Behind Bars': FCC Clears Way For Prisons To Jam Contraband Cellphones Authored by Tom Gantert via The Epoch Times,The Federal Communications Commission (FCC) voted Thursday to adopt rules allowing state and local correctional facilities to jam signals from cellphones smuggled to inmates.FCC Chairman Brendan Carr said that drones were being used to drop cellphones into prison yards, and that local officials ne
View source ↗ - 4chan /biz/biz·1d ago·Neutral
>>62941993 >JNJ is still green Baby oil sales for butt blasting red candles are going great right now
View source ↗ - News (Marketaux)thestockmarketwatch.com·2d ago·Neutral
[DowJonesToday]Dow Jones Pulls Back Amid Economic Uncertainty and Tech Volatility Other notable performers included Jo[+241 characters]
View source ↗ - News (RSS)zerohedge·2d ago·Neutral
Watch: New Pentagon UFO Files Drop Warship Video And Skinwalker Ranch Secrets Watch: New Pentagon UFO Files Drop Warship Video And Skinwalker Ranch Secrets The Department of War's eighth batch of UFO files, out Friday, carries a 2020 infrared clip from the Middle East in which a tiny object glowing white hot appears to fly across the bow of a warship, according to files and footage the Daily Mail obtained ahead of the release.EXCLUSIVE: Never-before-seen Pentagon video shows a tiny object glowin
View source ↗ - News (Marketaux)seekingalpha.com·2d ago·Neutral
Dividend Roundup: Nvidia, Disney, Merck, Johnson & Johnson and more Additionally, looking towards next week,[+75 characters]
View source ↗ - News (RSS)investing·2d ago·Negative
Johnson & Johnson drug shows improvement in axial psoriatic arthritis
View source ↗ - News (Marketaux)rte.ie·2d ago·Positive
Limerick-based J&J eye care firm records €501m in profits A Limerick based unit of US healthcare g[+289 characters]
View source ↗ - Newsprnewswire.com·2d ago·Neutral
… assessments to confirm and measure axial inflammation alongside patient-reported symptoms NEW BRUNSWICK, N.J., Nov. 20, 2026 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ) today announced late-breaking results from the Phase 4 STAR study of TREMFYA (guselkumab) in biologic-naïve adults with active psoriatic arthritis and axial involvement (axial PsA).
View source ↗ - News (RSS)fool·2d ago·Negative
Johnson & Johnson Delivered 'Immaculate' Prostate Cancer Data at ESMO. Here's Why Investors Should Care Johnson & Johnson's $3.05 billion Halda bet is already paying off in the clinic.
View source ↗ - Newszacks.com·3d ago·Negative
Stock Screening Made Simple: A Closer Look Stock screening is commonly deployed by investors to 'cut through the noise.' The approach is especially useful when you're choosing from thousands of options, which can often overwhelm investors.
View source ↗ - News (RSS)cointelegraph·3d ago·Negative
Trump’s SEC nominee Johnson backs formal rulemaking for tokenized stock trading Former CFTC Commissioner and Democrat Kristin Johnson and ex-SEC aide Steven Levine appeared before lawmakers Thursday.
View source ↗ - News (Marketaux)thestockmarketwatch.com·3d ago·Negative
[DowJonesToday]Dow Jones Plummets as Economic Uncertainty Weighs on Blue-Chip Stocks Other notable gainers included Johns[+259 characters]
View source ↗ - Newsfool.com·3d ago·Negative
Johnson & Johnson Delivered 'Immaculate' Prostate Cancer Data at ESMO. Here's Why Investors Should Care Johnson & Johnson's JNJ-6143 posted excellent results in an early-stage clinical trial. For income investors, the real story is a Dividend King with a deep lineup and pipeline.
View source ↗ - News (RSS)seekingalpha·3d ago·Neutral
Johnson Matthey Plc 2027 Q2 - Results - Earnings Call Presentation
View source ↗ - News (RSS)zerohedge·3d ago·Neutral
Futures Rip As Anthropic IPO Frenzy Revives AI Trade, Asian Chips Puke Futures Rip As Anthropic IPO Frenzy Revives AI Trade, Asian Chips Puke US futures are higher, with Nasdaq contracts ripping as much as 2% after Anthropic's blockbuster IPO priced well above its marketed range and revived the battered AI trade, while traders shrug off a fresh round of Iran escalation (Trump is reportedly weighing new strikes and the IRGC claims two supertankers hit mines in Hormuz) and parse the first ever Tru
View source ↗ - News (RSS)investing·3d ago·Positive
Johnson Matthey says demand for pollution filters used at AI data centres outstrips supply
View source ↗ - News247wallst.com·3d ago·Neutral
Want Steady Dividend Income? Invest in These 3 Dividend Kings With 64 Years of Raises Each of the three covers its payout with recurring cash flow, investment-grade discipline and decades of annual raises.
View source ↗ - News (RSS)investing·3d ago·Positive
Why is Johnson Matthey stock rallying today?
View source ↗ - Newsprnewswire.com·3d ago·Negative
…lerability profile across major depressive disorder, bipolar depression and schizophrenia NEW BRUNSWICK, N.J., Nov. 19, 2026 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) seeking the approval of CAPLYTA (lumateperone) for the treatment of manic or mixed episodes associated with bipolar I disorder in adults.
View source ↗ - News247wallst.com·4d ago·Neutral
Invest $25,000 in These 4 Dividend Stocks to Start Building Retirement Income Retirement changes what a portfolio is for. Once the paycheck stops, the number that matters most is how much cash the account sends back each year without pushing a sale of shares.
View source ↗ - News247wallst.com·4d ago·Neutral
Here's How Much Passive Income $50,000 Generates in These 4 Dividend Aristocrats Four household-name stocks have raised their dividends for 40 to 70 straight years, yet each one carries a risk that could threaten the streak. Which payout looks safest, and which check is biggest?
View source ↗ - News (RSS)zerohedge·4d ago·Neutral
"Sort Of Run Out Of Options": Ex-CIA Vets Who Warned Trump Iran Could Strike First Say He Isn't Being Told What His Spies Know "Sort Of Run Out Of Options": Ex-CIA Vets Who Warned Trump Iran Could Strike First Say He Isn't Being Told What His Spies Know Former CIA analyst Larry Johnson says the United States "doesn't have any good military options left" against Iran, and that the newest US intelligence count of Iran's missiles badly lowballs what Tehran still holds. Surface-to-surface 4th genera
View source ↗ - News (Marketaux)thestockmarketwatch.com·4d ago·Positive
[DowJonesToday]Dow Jones Plummets as Inflation Concerns and Retail Weakness Weigh on Markets Other notable gainers included Johns[+295 characters]
View source ↗ - News (Marketaux)thestockmarketwatch.com·5d ago·Neutral
[DowJonesToday]Dow Jones Plummets as Inflation Concerns Weigh on Market Sentiment Other notable performers included Jo[+315 characters]
View source ↗ - News (RSS)fool·5d ago·Neutral
Johnson & Johnson vs. Pfizer: Consistency vs. Volatility in Revenue J&J's quarterly sales have climbed with few setbacks, while Pfizer's have swung between $13.7 billion and $17.8 billion over eight quarters.
View source ↗ - News (Marketaux)thehindubusinessline.com·5d ago·Positive
Isomorphic Labs raises $5 billion in Series C funding for AI drug discovery which uses AI to design new drugs, predi[+333 characters]
View source ↗ - Newsbusinesswire.com·5d ago·Positive
Louisiana Appeals Court Upholds Millions in Damages in Mesothelioma Case Against Johnson & Johnson DALLAS--(BUSINESS WIRE)--An appeals court in Louisiana has upheld a multimillion verdict against Johnson & Johnson, in which a jury found that talc in its baby powder caused a New Orlean's woman's mesothelioma and death.In a Nov. 16 ruling, Louisiana's Fourth Circuit Court of Appeal affirmed a trial court's decision to increase damages awarded to the family of Jeannine Henderson. National plaintiff…
View source ↗ - News (Marketaux)thestockmarketwatch.com·5d ago·Positive
[DowJonesToday]Dow Jones Slips as Market Weighs Economic Uncertainty Other notable performers included health[+235 characters]
View source ↗ - Newszacks.com·5d ago·Positive
J&J to Acquire Ollin Biosciences: A Look at Its Recent Buyouts J&J's $2.2 billion Ollin Biosciences deal adds a promising retinal disease candidate, building on acquisitions.
View source ↗ - Newszacks.com·5d ago·Neutral
J&J to Boost Ophthalmology Pipeline With $2.2B Ollin Acquisition JNJ's $2.2 billion Ollin acquisition adds a phase III eye disease candidate to its pipeline, with Blackstone providing $750 million to fund the development.
View source ↗ - Newszacks.com·5d ago·Neutral
Wall Street Analysts Think Johnson & Johnson (JNJ) Is a Good Investment: Is It? Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
View source ↗ - Newszacks.com·5d ago·Neutral
Here is What to Know Beyond Why Johnson & Johnson (JNJ) is a Trending Stock Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
View source ↗ - News247wallst.com·5d ago·Positive
3 Bulletproof Passive Income Dividend Kings to Buy and Hold Forever A pending IRS ruling, rising commodity costs, and more test whether the payouts of these passive income Dividend Kings can survive.
View source ↗ - Newsfool.com·5d ago·Positive
Johnson & Johnson vs. Novo Nordisk: Steady Uptrend vs. Johnson & Johnson currently exhibits a stronger overall position by generating a substantially larger total revenue volume than Novo Nordisk. Johnson & Johnson maintained a consistent quarter-over-quarter upward trajectory, while Novo Nordisk reported mostly flat U.S. dollar figures with the exception of one isolated spike.
View source ↗ - News (RSS)zerohedge·5d ago·Negative
Three Men & A Photo Op: What To Expect In Shenzhen Three Men & A Photo Op: What To Expect In Shenzhen Authored by Larry C. Johnson via Sonar21,On Thursday, November 19, in the Chinese tech hub of Shenzhen, Donald Trump will sit down with Vladimir Putin and Xi Jinping for a three-way conversation. Beijing's Foreign Ministry made it official on Monday, calling it the "China-Russia-United States Summit." The Kremlin had already announced it, and the White House had already bragged about it.It reall
View source ↗ - News (RSS)japantimes·5d ago·Neutral
Brexit the sequel? Leave voices reorganize as Burnham chases EU reset Former Prime Minister Boris Johnson insisted the country would back Brexit again in another referendum — despite polls suggesting the opposite.
View source ↗ - News (Marketaux)thestockmarketwatch.com·5d ago·Positive
[DowJonesToday]Dow Jones Plummets as Rate Uncertainty and Tech Volatility Weigh on Markets Tech giant Nvidia (NVDA) also showed res[+281 characters]
View source ↗ - News (RSS)cointelegraph·6d ago·Negative
Boris Johnson says UK must lead blockchain development despite crypto doubts Johnson was joined by Lord Ross Kempsell who called for regulators to work with industry participants to bring the UK to the forefront.
View source ↗ - News (Finnhub)CNBC·6d ago·Neutral
Jim Cramer says J&J is a 'metaphor for what's working' in the stock market Johnson & Johnson is a prime example of the kind of stocks doing well as investors shy away from the volatile AI trade.
View source ↗ - News (Marketaux)thestockmarketwatch.com·6d ago·Positive
[DowJonesToday]Dow Jones Slumps as Inflation Concerns and Tech Volatility Weigh on Markets Artificial intelligence bellwether Nvidi[+269 characters]
View source ↗ - News (RSS)wsj·6d ago·Positive
Johnson & Johnson to Buy Ollin Biosciences for $2.2 Billion Johnson & Johnson has agreed to buy Ollin Biosciences, a clinical-stage biopharmaceutical company developing therapies for serious eye diseases.
View source ↗ - News (RSS)zerohedge·6d ago·Neutral
…er Nvidia chips reaching China); Anthropic's IPO, reportedly six times oversubscribed, is expected to price on Wednesday and start trading on the Nasdaq on Thursday; Johnson & Johnson is in talks to buy eye-disease drug developer Ollin Biosciences for as much as $3.4 billion (FT); Diamondback Energy is in talks to buy Double Eagle V for about $5 billion; Canadian Natural Resources agreed to buy Advantage Energy for C$2.255 billion; UniCredit got the Fed's nod to complete its Commerzbank deal; UL…
View source ↗ - Newszacks.com·6d ago·Neutral
J&J Stock Rallies More Than 10% in a Month: Time to Buy, Sell or Hold? JNJ's rally reflects stronger earnings and promising drug launches, but MedTech weakness, patent losses and litigation risks remain.
View source ↗ - Newswsj.com·6d ago·Positive
Johnson & Johnson to Buy Ollin Biosciences for $2.2 Billion Johnson & Johnson has agreed to buy Ollin Biosciences, a clinical-stage biopharmaceutical company developing therapies for serious eye diseases.
View source ↗ - News (Marketaux)seekingalpha.com·6d ago·Neutral
J&J in discussions to buy Ollin Biosciences for up to $3.4B - report Johnson & Johnson (JNJ[+224 characters]
View source ↗ - News (RSS)ft·6d ago·Negative
Johnson & Johnson looking to buy eye disease biotech for up to $3.4bn Drugmaker’s potential acquisition of Ollin Biosciences is latest in glut of deals in biotechnology sector
View source ↗ - News (RSS)seekingalpha·7d ago·Neutral
Kura Oncology: JNJ's Bleximenib Is A Serious Threat, But Kura Still Has A Fighting Chance
View source ↗ - News (RSS)zerohedge·7d ago·Neutral
Your Shopping Bag Runs Through Hormuz Your Shopping Bag Runs Through Hormuz Authored by Larry C. Johnson via Sonar21,Every morning the cable networks put up the price of Brent and a graphic of a tanker, and every evening the experts reassure us that the oil is still flowing, more or less. Crude is the scoreboard everyone watches. It is also the wrong scoreboard.Iran has hit roughly fifty ships in and around the Strait of Hormuz since September 1, most of them tankers. Against a world fleet of mo
View source ↗ - PodcastAll In·8d ago·Neutral
China but lagging chips like the age 20 could be sold in unlimited quantities to China on an unlicensed basis okay so just everyone kind of keep that in mind now what happened in the Trump administration the Trump administration basically stuck with that framework the idea was no leading edge chips to China however lagging chips could potentially be sold but the administration changed it to be limited quantities on a license basis so again we went from unlimited quantities unlicensed of lagging
View source ↗ - PodcastAll In·8d ago·Negative
of Apple obviously had a tough job in the shadow of Steve Jobs but the reality is that they did not release that many new products they created incremental versions of what they already had and I think that the mobile phone space is just a little different than chips I think the chip space is more dynamic it's more competitive like I mentioned new chip generation every year or so every year and a half and if you lose a tempo or two if you lose velocity I think that's the key word here that freeb
View source ↗ - News (Marketaux)thestockmarketwatch.com·9d ago·Positive
[DowJonesToday]Dow Jones Futures Rise Amid Mixed Sector Performance Other notable gainers providing a cushio[+260 characters]
View source ↗ - News (Marketaux)thestockmarketwatch.com·10d ago·Positive
[DowJonesToday]Dow Jones Gains Momentum Amid Key Earnings and Economic Resilience Defensive plays also saw gains, as J[+270 characters]
View source ↗ - News (RSS)zerohedge·10d ago·Neutral
"This One Smells": Ex-CIA Analyst Says Russian Death Toll Leak Arrived Right On Cue "This One Smells": Ex-CIA Analyst Says Russian Death Toll Leak Arrived Right On Cue Authored by Larry C. Johnson via Sonar21,In the intelligence business, timing is everything. On February 5, 2026, Finland's National Defence University, which is hardly a Kremlin front, posted a paper by Alexander Grable titled "Irretrievable Losses: Casualties in the Russo-Ukraine War (2022 - present)." Grable concluded that Ukra
View source ↗ - 4chan /biz/biz·10d ago·Neutral
huhwang Johnson will simply create a new Nvidia where you're encouraged to have sex
View source ↗ - News (RSS)zerohedge·10d ago·Neutral
Trump And Texas' New Democrat Governor Are Headed For War Over The Border Trump And Texas' New Democrat Governor Are Headed For War Over The Border The midterms did more than change which party will control Congress for the next year. By electing Gina Hinojosa governor, Texas voters ended a decade-long partnership between Austin and Washington on the border and set the state on a collision course with the Trump administration over immigration enforcement. Texas Governor-elect Gina Hinojosa speak
View source ↗ - 4chan /biz/biz·10d ago·Neutral
they really want Johnson Richard Wang out
View source ↗ - News (Marketaux)thestockmarketwatch.com·11d ago·Positive
[DowJonesToday]Dow Jones Gains Ground Amid Industrial Strength and AI Momentum Defensive sectors also showed strength; [+318 characters]
View source ↗ - News (RSS)zerohedge·11d ago·Neutral
Thune Tells Democrats "Republicans Are Ready To Work With You" - Then Draws The Line Thune Tells Democrats "Republicans Are Ready To Work With You" - Then Draws The Line Senate Republicans kept John Thune as their leader on Tuesday, brushing aside a push by seven GOP senators to delay the vote a day after Thune went to the floor and told incoming Democrats that "Republicans are ready to work with you."Thune will lead from the minority after Democrats flipped seven Republican-held seats on Nov. 3
View source ↗ - News (RSS)zerohedge·11d ago·Neutral
"Offense, Not Defense": Jordan Crushes Scalise To Lead Shrunken GOP Into Subpoena War "Offense, Not Defense": Jordan Crushes Scalise To Lead Shrunken GOP Into Subpoena War House Republicans picked Judiciary Chairman Jim Jordan on Tuesday to lead them into the minority, 106-73 over Majority Leader Steve Scalise in a secret ballot a week after a midterm wipeout handed Democrats their biggest House majority in decades, CBS reported. The Ohio Republican sold himself to colleagues as the man to take
View source ↗ - News (RSS)cnbc·11d ago·Neutral
Rep. Jim Jordan, Sen. John Thune elected GOP leaders in Congress House Speaker Mike Johnson, R-La., announced the day after Election Day he would not run for minority leader in the 120th Congress.
View source ↗ - News (RSS)forbes·12d ago·Neutral
INDY NXT Champion Nikita Johnson Graduates To IndyCar With Dale Coyne After becoming the youngest champion in INDY NXT By Firestone history, 18-year-old Nikita Johnson will be the youngest driver on the grid in IndyCar in 2027.
View source ↗ - News (RSS)zerohedge·12d ago·Neutral
"Could Be First Shoe To Drop": AI Power Stocks Tumble As SoftBank's Write-Down Deepens Bubble Fears "Could Be First Shoe To Drop": AI Power Stocks Tumble As SoftBank's Write-Down Deepens Bubble Fears GE Vernova and Bloom Energy shares plunged Tuesday after SoftBank Group disclosed a $3.7 billion charge tied to power equipment procurement. We asked whether this write-down, cancellation, or "revised procurement strategy" in the AI spending boom could signal trouble ahead in a note titled "Masa's $
View source ↗ - News (RSS)zerohedge·12d ago·Neutral
HUD Announces Largest Decrease In Homelessness On Record HUD Announces Largest Decrease In Homelessness On Record Authored by Naveen Athrappully via The Epoch Times,The Department of Housing and Urban Development (HUD) announced a 6.3 percent annual decrease in homelessness in the United States, the largest decline on record.HUD said that on a single night in January 2026, 698,425 individuals were homeless, 6.3 percent fewer than January 2025, when President Donald Trump took office. The decline
View source ↗ - News (Marketaux)thestockmarketwatch.com·12d ago·Neutral
[DowJonesToday]Dow Jones Slumps as Post-Election Rally Cools Amid Economic Uncertainty Tech giant Nvidia (NVDA) also showed res[+242 characters]
View source ↗ - News (RSS)zerohedge·12d ago·Neutral
The Other Shoe Has Dropped: DOJ Investigating Marc Elias In Peltola Scandal Case The Other Shoe Has Dropped: DOJ Investigating Marc Elias In Peltola Scandal Case Authored by Tim O'Brien via PJ Media,On October 29, I openly wondered whether the "stench of Alaska's Peltola scandal would spread to Marc Elias." Wonder no more.According to Just the News, the shady leftist lawyer who is best known for his work smearing President Donald Trump with the Russiagate hoax is now implicated in a scandal that
View source ↗ - Newszacks.com·12d ago·Negative
J&J's Oncology Sales Surge So Far in 2026: What Lies Ahead? J&J's oncology sales surge 16.8% to $22 billion in the first nine months of 2026, fueled by blockbuster drugs and new launches.
View source ↗ - Newsreuters.com·12d ago·Neutral
J&J eyes US nod for Caplyta in bipolar mania after second trial win J&J eyes US nod for Caplyta in bipolar mania after second trial win
View source ↗ - Newsprnewswire.com·12d ago·Negative
…inforcing its potential to address both depressive and manic episodes of bipolar disorder NEW BRUNSWICK, N.J., Nov. 10, 2026 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that Study 452, the second pivotal Phase 3 study evaluating CAPLYTA (lumateperone) for the treatment of manic episodes with or without mixed features in adults with bipolar I disorder, met its primary and key secondary endpoints.
View source ↗ - News (RSS)zerohedge·12d ago·Neutral
Senate Republicans Revolt Against Their Own Leaders Senate Republicans Revolt Against Their Own Leaders A bloc of Senate Republicans led by Sen. Ron Johnson (R-WI) is pushing to postpone Tuesday's GOP leadership elections, arguing that the conference needs time to examine its midterm election losses before it picks the leaders who will guide it in the minority. Sen. Ron Johnson and Sen. Rick Scott. (Finn Gomez/Getty Images) Democrats won control of the Senate with 54 seats, and that total could
View source ↗ - News (RSS)zerohedge·13d ago·Negative
Massie Starts The Clock On Hegseth's Impeachment - Here's How Many Republicans He Needs Massie Starts The Clock On Hegseth's Impeachment - Here's How Many Republicans He Needs Rep. Thomas Massie (R-Ky.) introduced eight articles of impeachment against Defense Secretary Pete Hegseth on the House floor Monday afternoon, and because the resolution is privileged, the House has to take it up within two legislative days, Fox News reported, which would put the vote no later than Wednesday. Defense Secr
View source ↗ - 4chan /biz/biz·13d ago·Neutral
>>62879394 Johnson Huwite is a filthy race traitor We used to be a proper country
View source ↗ - News (RSS)zerohedge·13d ago·Neutral
'A Working Group For War And Peace': Three Hours In The Kremlin 'A Working Group For War And Peace': Three Hours In The Kremlin Authored by Larry C. Johnson via Sonar21Vladimir Putin does not give three hours of his time to people who have nothing to say. On Thursday, he gave three hours to Mohsen Rezaei, the secretary of Iran’s Supreme National Security Council. Two days later, Israel's president handed the job of forming the next government to Gadi Eisenkot instead of Benjamin Netanyahu.Washin
View source ↗ - Newsprnewswire.com·14d ago·Neutral
…h investigational pasritamig-based immunotherapy combination in advanced prostate cancer First-of-its-kind dual-antigen-targeted bispecific regimen of pasritamig and JNJ-9401 directed at two prostate cancer proteins, KLK2 and PSMA, using complementary signals to activate T cells against cancer Deep and sustained PSA responses observed with every-six-week dosing, with 73% (11 of 15 patients) achieving reductions of at least 50% and nearly half achieving reductions of at least 90% in Phase 1 study…
View source ↗ - News (RSS)zerohedge·14d ago·Neutral
Ex-CIA Officer Says The Agency Delivered The Same Iran Verdict Three Times Before The War Ex-CIA Officer Says The Agency Delivered The Same Iran Verdict Three Times Before The War Former CIA officer John Kiriakou says the agency produced three separate national intelligence estimates before the Iran war began, and each one found that Tehran had no nuclear weapons program. He made the claim on the Nov. 6 "Intelligence Community Roundtable" edition of Judge Andrew Napolitano's Judging Freedom, alo
View source ↗ - Newsprnewswire.com·15d ago·Negative
…ignificant joint and skin improvements and a favorable safety profile in a once-daily pill NEW BRUNSWICK, N.J., Nov. 7, 2026 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced positive results from a Phase 3 study investigating ICOTYDE® (icotrokinra) in biologic-naïve adults with active psoriatic arthritis (PsA).a,b ICOTYDE is the first and only targeted oral peptide that precisely blocks the IL-23 receptor.1 ICOTYDE met the primary endpoint, with 58% of patients achieving an American…
View source ↗ - Newsprnewswire.com·15d ago·Negative
… evaluating nipocalimab in Sjögren's disease including these measures critical to patients NEW BRUNSWICK, N.J., Nov. 7, 2026 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced new patient experience findingsa from the Phase 2 DAHLIAS study of nipocalimab in Sjögren's disease (SjD), a chronic, systemic autoantibody-driven disease affecting approximately four million people worldwide.1 The results show that mouth dryness is the symptom improvement that matters most to patients,2 complem…
View source ↗ - Newsreuters.com·15d ago·Neutral
J&J's once-daily pill eases psoriatic arthritis symptoms in late-stage trial J&J's once-daily pill eases psoriatic arthritis symptoms in late-stage trial
View source ↗ - News (Marketaux)thestockmarketwatch.com·16d ago·Neutral
[DowJonesToday]Dow Jones Remains Flat as Industrial Strength Offsets Tech and Retail Weakness Other notable gainers providing stabilit[+243 characters]
View source ↗ - News (RSS)zerohedge·16d ago·Neutral
If You Lie To Voters About Not Starting A New War, The Voters Make You Pay If You Lie To Voters About Not Starting A New War, The Voters Make You Pay Authored by Larry C. Johnson via Sonar21,American voters have a long memory for one particular kind of broken promise. Tell them you will keep their sons out of a foreign war, then march them into one, and they will eventually send you a bill. In 1920 the Democrats paid it. On Tuesday, the Republicans did.On election night 2024, Donald Trump told a
View source ↗ - News247wallst.com·16d ago·Neutral
The Average 1-Year CD Pays Just 1.76%. These Dividend Stocks Could Pay More A guaranteed bank rate sounds safe until you weigh what it can't do.
View source ↗ - Newszacks.com·16d ago·Negative
JNJ's Innovative Medicine Unit Grows in Q3 Despite Patent Losses J&J's Innovative Medicine sees a 7.7% rise in Q3 sales to $16.76 billion, as blockbuster drugs and new launches offset generic headwinds.
View source ↗ - News (RSS)investing·16d ago·Neutral
Johnson & Johnson wins FDA approval for Rybrevant cancer treatment
View source ↗ - News (RSS)zerohedge·16d ago·Negative
Ex-School Board President Indicted In Alleged $1.3 Million Kickback Over $2.7 Million COVID-Funded Air Purifier Deal Ex-School Board President Indicted In Alleged $1.3 Million Kickback Over $2.7 Million COVID-Funded Air Purifier Deal A federal grand jury in Chicago has indicted Annette Johnson, the former president of the East Aurora School District 131 Board of Education, on charges that she entered the district into a $2.7 million air purifier purchase in 2021 in exchange for a $1.3 million pa
View source ↗ - News (RSS)zerohedge·16d ago·Neutral
Why Are We Being Warned That Our "Window To Prepare" Is Closing? Why Are We Being Warned That Our "Window To Prepare" Is Closing? Authored by Michael Snyder via The Economic Collapse,There is growing anticipation that something really big is about to happen. Social media is buzzing about the fact that so many governments around the world are urging their citizens to stockpile food, water and other essential supplies right now. Why have all of those governments suddenly developed such a sense of
View source ↗ - Newsprnewswire.com·17d ago·Negative
…oth EGFR and MET pathways – two key drivers of tumor progression in head and neck cancer2 NEW BRUNSWICK, N.J., Nov. 5, 2026 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) granted accelerated approval for RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) (subcutaneous injection, 160 mg/2,000 units per mL) as a single agent for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) who…
View source ↗ - News (RSS)zerohedge·17d ago·Negative
Mike Johnson To Step Down As Top House Republican After Election Loss Mike Johnson To Step Down As Top House Republican After Election Loss Authored by Zachary Stieber via The Epoch Times,House Speaker Mike Johnson (R-La.) is no longer going to be the top Republican in the House soon.Johnson will not run to be the Republican House leader in the next Congress, a spokesman told The Epoch Times in an email on Nov. 4.Johnson, 54, has been House speaker since 2023 and won another term representing Lo
View source ↗ - News (RSS)zerohedge·17d ago·Neutral
Futures Split As Blue-Wave Chip Purge Enters Day Two; Oil Rebounds, BoE Hikes Futures Split As Blue-Wave Chip Purge Enters Day Two; Oil Rebounds, BoE Hikes US futures are mixed, with the Nasdaq lagging as the post-midterm rotation out of chipmakers and the AI complex enters a second day, after the Democratic sweep raised fears of a data center backlash, Qualcomm tumbled on a weak forecast and the Kospi crashed almost 6%, while oil rebounded modestly from Wednesday's plunge and the BoE hiked rate
View source ↗ - News247wallst.com·17d ago·Negative
3 Dependable Dividend Stocks for a $250,000 Passive Income Strategy Some stocks are worth holding for decades, and they usually have one thing in common: a dividend that went up every year through recessions, rate shocks and bear markets.
View source ↗ - News (Marketaux)thestockmarketwatch.com·18d ago·Positive
[DowJonesToday]Dow Jones Surges Amid Post-Election Market Volatility Technology and healthcare giants also pr[+285 characters]
View source ↗ - News (RSS)zerohedge·18d ago·Neutral
"Extinction-Level Event": Takeaways From The GOP's Midterm Wipeout "Extinction-Level Event": Takeaways From The GOP's Midterm Wipeout Democrats flipped seven Republican-held Senate seats and seized the House on Tuesday, handing President Trump what Punchbowl News called "an extinction-level event" for the GOP. As of Wednesday morning, NBC News had the Senate at 54-44 with two races still out. In Mississippi, Democrat Scott Colom led Sen. Cindy Hyde-Smith by 43 votes with more than 95% counted. I
View source ↗ - News (RSS)zerohedge·18d ago·Neutral
Bearish Beyond The 'Blue Wave' Bounce Bearish Beyond The 'Blue Wave' Bounce Submitted by QTR's Fringe FinanceWell, the voters have spoken. Screamed, actually. And if last night’s election results were supposed to provide some kind of reprieve for the Trump administration, they did precisely the opposite. Democrats delivered a decisive, sweeping victory, taking control of both the House and Senate and flipping seats in places Republicans have considered safe for generations.“Democrats are on trac
View source ↗ - Newsreuters.com·18d ago·Neutral
Smith+Nephew cuts outlook, confirms failed merger talks with J&J's orthopaedics unit Smith+Nephew cuts outlook, confirms failed merger talks with J&J's orthopaedics unit
View source ↗ - News (Marketaux)thestockmarketwatch.com·19d ago·Negative
[DowJonesToday]Dow Jones Slips as Election Day Uncertainty Grips Wall Street Healthcare and defensive names also show[+244 characters]
View source ↗
Earnings
Tue, Jan 26(in 2 months)
Consensus estimate $2.91 per share
Typical surprise +1.8% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Oct 13$2.59 vs $2.52beat
- Wed, Jul 15$2.90 vs $2.85beat
- Tue, Apr 14$2.70 vs $2.68beat
- Wed, Jan 21$2.46 vs $2.46beat
- Tue, Oct 14$2.80 vs $2.76beat
- Wed, Jul 16$2.77 vs $2.68beat
Estimates and results for JNJ via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by JNJ officers and directors.
- Bought
- —
- Sold
- $87.3m
0 trades
16 trades
- Forminard Elizabethsold
- Schmid Timothysold
- Taubert Jennifer Lsold
- Duato Joaquinsold
- Duato Joaquinsold
- Forminard Elizabethsold
- Forminard Elizabethsold
- Duato Joaquinsold
84 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Thomas Keanhouse · NJ07 · disclosed Nov 19, 2026 (23d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 9, 2026 (33d later)Sell$100,001 - $250,000
- Thomas Keanhouse · NJ07 · disclosed Oct 30, 2026 (30d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Oct 9, 2026 (14d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Oct 9, 2026 (35d later)Buy$15,001 - $50,000
- Lloyd Doggetthouse · TX37 · disclosed Oct 6, 2026 (28d later)Buy$1,001 - $15,000
- Thomas Keanhouse · NJ07 · disclosed Sep 14, 2026 (18d later)Sell$1,001 - $15,000
- John Boozmansenate · AR · disclosed Sep 11, 2026 (22d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Sep 7, 2026 (31d later)Sell$1,001 - $15,000
- Rich McCormickhouse · GA06 · disclosed Aug 17, 2026 (18d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Aug 12, 2026 (41d later)Buy$1,001 - $15,000
- Thomas Hawley Tubervillesenate · AL · disclosed Aug 5, 2026 (645d later)Sell$15,001 - $50,000
- Alan Armstrongsenate · disclosed Jul 21, 2026 (113d later)Buy$1,001 - $15,000
- Alan Armstrongsenate · disclosed Jul 21, 2026 (116d later)Buy$15,001 - $50,000
- Thomas Keanhouse · NJ07 · disclosed Jul 16, 2026 (44d later)Sell$1,001 - $15,000
- Thomas Keanhouse · NJ07 · disclosed Jul 16, 2026 (17d later)Sell$1,001 - $15,000
- Lloyd Doggetthouse · TX37 · disclosed Jul 7, 2026 (28d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Jun 11, 2026 (41d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed May 13, 2026 (30d later)Buy$15,001 - $50,000
- John Boozmansenate · AR · disclosed Apr 14, 2026 (26d later)Sell$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
